Clinical Trials Directory

Trials / Completed

CompletedNCT00585338

Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
1 (actual)
Sponsor
University of California, Irvine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Dermatologists have for many years treated vascular lesions by a variety of modalities including cryosurgery, electrotherapy, dermabrasion and radiation. It has been hypothesized that simultaneous delivery of these two wavelengths may provide safer, and in some cases more effective, vascular lesion removal. The Tandem laser is capable of emitting multiple cryogen spurts intermittently with multiple 532/1064 nm laser pulses.This mode may reduce malformed blood vessels with a low incidence of long-term side effects.

Detailed description

The researcher can determine the blanching of vascular lesions after Tandem laser with multiple 532/1064 nm laser pulses treatment. The researcher will select one to four test sites spots for laser treatment. will be Different laser parameters can be used for each test site. The research will evaluate of the test sites at 6-12 weeks for bruising and blanching. Parameters of the test area with the greatest degree of blanching without adverse effects will be utilized for further treatment. If no test area is determined to have blanching without adverse effects, further test sites may be performed.

Conditions

Interventions

TypeNameDescription
DEVICETandem 532/1064 nm LaserTreatment of Vascular Lesions With a Tandem 532/1064 nm Laser

Timeline

Start date
2007-12-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2008-01-03
Last updated
2022-10-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00585338. Inclusion in this directory is not an endorsement.

Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser (NCT00585338) · Clinical Trials Directory